초록 ▼

An implantable cardioverter/defibrillator includes an active can electrode and a high-voltage lead that can be electrically isolated from one another by opening a switch between them. The performance of the high-voltage lead and the can electrode can then be independently monitored, thus indicating

An implantable cardioverter/defibrillator includes an active can electrode and a high-voltage lead that can be electrically isolated from one another by opening a switch between them. The performance of the high-voltage lead and the can electrode can then be independently monitored, thus indicating which lead is inoperable, should one become inoperable. If a lead becomes inoperable, the implantable device can then reconfigure an electrical pathway such as a cardioversion and/or a defibrillation pathway by excluding the inoperable lead. By separating the high-voltage lead from the can electrode, pseudo ECG measurements can also be taken and utilized by the implantable device.

대표청구항 ▼

What is claimed is: 1. A method for use in an Implantable Medical Device (IMD), wherein the IMD includes a housing functioning as a can electrode, comprising: coupling a high-voltage lead to the can electrode; coupling a second lead to the can electrode; selectively electrically coupling and decoup

What is claimed is: 1. A method for use in an Implantable Medical Device (IMD), wherein the IMD includes a housing functioning as a can electrode, comprising: coupling a high-voltage lead to the can electrode; coupling a second lead to the can electrode; selectively electrically coupling and decoupling the high-voltage lead from the can electrode; measuring a first impedance between the can electrode and the high-voltage lead in response to the can electrode and the high-voltage lead being electrically coupled; and determining whether the high-voltage lead is present in response to the first impedance and enabling a non-therapy related function dependent upon the high-voltage lead being present. 2. The method of claim 1, wherein the enabling a non-therapy related function comprises generating cardiac cycle data via the high voltage lead and the can electrode in response to the high voltage lead being present and via other than the high voltage lead and the can electrode in response to the high voltage lead not being present. 3. An implantable medical device (IMO) comprising: a control circuit; a housing coupled with the control circuit and acting as a can electrode; a first lead coupled with the control circuit and the housing; a second lead coupled to the housing; a switch coupled between the first lead and the can electrode, wherein the control circuit controls the switch to selectively decouple the first lead from the can electrode; and an impedance measurement circuit measuring a first impedance between the can electrode and the first lead in response to the control circuit electrically coupling the can electrode and the first lead, wherein the control circuit determines the first lead is present in response to the first impedance and enables a non-therapy related function dependent upon the first lead being present, wherein the impedance measurement circuit measures a second impedance between The second lead and the can electrode and a third impedance between the first lead and the second lead, and the control circuit includes means for determining if one of the can electrode, the first lead and the second lead is inoperable based on the measured impedance, and wherein, in response to one of the can electrode, the first lead and the second lead being inoperable, the control circuit isolates the one of the can electrode, the first lead and the second lead from a predetermined cardioversion pathway. 4. The IMD of claim 3, wherein the control circuit includes circuits to deliver a sub-threshold pulse. 5. The IMD of claim 4, wherein the first lead is selected from the group consisting of an SVC lead, an RV lead, a coronary sinus lead, and a subcutaneous lead. 6. The IMD of claim 4, wherein one of the first lead and the second lead is determined operable if the measured impedance is between about 20-200 ohms. 7. The IMD of claim 4, wherein the control circuit determines whether the first lead is operable in response to the first impedance and includes circuits to disable the first lead when the first lead is determined to be inoperable. 8. The IMD of claim 4, wherein the control circuit includes circuits to disable the first lead prior to the control circuit determining that the first lead is present.